Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
The Urologic Clinics of North America|April 14, 2018
Robotic CystectomyDanica May, Jessie Gills, Scott E DelacroixUrology|November 19, 2018
Effect of the Need for Preoperative Dialysis on Perioperative Outcomes on Patients Undergoing Laparoscopic Nephrectomy: An Analysis of the National Surgical Quality Improvement Program DatabaseDanica May, Dunia Khaled, Marc R Matrana, et al.The Urologic Clinics of North America|November 24, 2019
Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical AgentsDunia Khaled, John Taylor, Jeffrey HolzbeierleinUrology Practice|July 25, 2025
Less Is More: Going Green in Urological ProceduresNicholas Choi, Danica May, Dane Stephens, et al.Bladder Cancer (Amsterdam, Netherlands)|December 31, 2016
The July Effect in Radical Cystectomy: Mortality, Morbidity, and EfficiencyKeegan Zuk, Derek Jensen, Jessie Gills, et al.The Journal of Urology|December 29, 2015
Current Practices of Measuring and Reference Range Reporting of Free and Total Testosterone in the United StatesMargaret Le, David Flores, Danica May, et al.Ochsner Journal|April 8, 2021
A Nurse-Driven Protocol for Foley Catheter Utilization Decreases the Incidence of Traumatic Foley CatheterizationEric Laborde, Hayden Hill, Thomas E Dukovac, et al.Trials|October 9, 2019
Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practicesShellie Ellis, Mugur Geana, Tomas Griebling, et al.The Journal of Urology|March 15, 2017
The Role of High Dose Interleukin-2 in the Era of Targeted TherapyJessie Gills, William P Parker, Scott Pate, et al.Urology|July 30, 2018
An Evaluation of Reported Follicle-stimulating Hormone, Luteinizing Hormone, Estradiol, and Prolactin Reference Ranges in the United StatesFrances Grimstad, Margaret Le, Andrew Zganjar, et al.Pageof 2